Asthma Clinical Trial
Official title:
A Cross Sectional Study for the Assessment of the Words Used by Patients and Physicians to Express Asthma Symptoms and the Limitations of Daily Activities in Primary Care. The " Asthma Language " Survey
| Verified date | December 2009 |
| Source | AstraZeneca |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | Greece: National Organization of Medicines |
| Study type | Observational |
The purpose of the study is to evaluate the concordance of the most frequently used words by the patients and the physicians to express asthma symptoms and the limitations of daily activities caused by asthma.
| Status | Completed |
| Enrollment | 696 |
| Est. completion date | December 2009 |
| Est. primary completion date | |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - Diagnosis of persistent asthma treated with inhaled corticosteroid-based maintenance treatment for at least 6 months and followed up by the investigator for at least the same period of time Exclusion Criteria: - Patient with a cardiac disease (congestive heart failure, coronary heart disease) - Patient with a respiratory disease other than asthma (COPD, sleep apnoea syndrome) |
Observational Model: Case-Only, Time Perspective: Cross-Sectional
| Country | Name | City | State |
|---|---|---|---|
| Greece | Research Site | Agrinio | Aitoloakarnanias |
| Greece | Research Site | Aikaterini | Peierias |
| Greece | Research Site | Amfisa | Fokidos |
| Greece | Research Site | Argos | Argolida |
| Greece | Research Site | Arta | Artas |
| Greece | Research Site | Athens | Attiki |
| Greece | Research Site | Chalkida | |
| Greece | Research Site | Chalkidiki | |
| Greece | Research Site | Chania | Crete |
| Greece | Research Site | Chrisoupoli | Kavalas |
| Greece | Research Site | Drama | Drammas |
| Greece | Research Site | Edessa | Pella |
| Greece | Research Site | Farsala | Larrisa |
| Greece | Research Site | Herakleion | Crete |
| Greece | Research Site | Igoumenitsa | Thesprotia |
| Greece | Research Site | Ioannina | Ioanninon |
| Greece | Research Site | Kalamata | Messinia |
| Greece | Research Site | Karditsa | Karditsis |
| Greece | Research Site | Kastoria | Florinas |
| Greece | Research Site | Kavala | Kavalas |
| Greece | Research Site | Komotini | Rodopi |
| Greece | Research Site | Ksanthi | Ksanthis |
| Greece | Research Site | Lakonia | |
| Greece | Research Site | Larisa | Larisas |
| Greece | Research Site | Livadia | Biotias |
| Greece | Research Site | Loutraki | Korinthia |
| Greece | Research Site | Naupaktos | Aitoloakarnania |
| Greece | Research Site | Patras | Achaia |
| Greece | Research Site | Peraious | Attiki |
| Greece | Research Site | Pirgos | Ilia |
| Greece | Research Site | Ptolemaida | Kozani |
| Greece | Research Site | Rethimno | Crete |
| Greece | Research Site | Rodos | Dodekanisou |
| Greece | Research Site | Salonika | Thessalonikis |
| Greece | Research Site | Serres | Serron |
| Greece | Research Site | Siros | Cyclades |
| Greece | Research Site | Thermo | Aitoloakarnanias |
| Greece | Research Site | Trikala | Trikalon |
| Greece | Research Site | Veroia | Imathia |
| Greece | Research Site | Volos | Magnisia |
| Lead Sponsor | Collaborator |
|---|---|
| AstraZeneca |
Greece,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | The concordance of the most frequently used words by the patients and the physicians to express asthma symptoms and the limitations of daily activities caused by asthma | Day 1 | No | |
| Secondary | The most frequently used words (lexical intensity) by the patient and the physician to express asthma symptoms and the limitations of daily activities. | Day 1 | No | |
| Secondary | The concordance of words used by physicians and patients according to the level of asthma control (as assessed by ACQ). | Day 1 | No | |
| Secondary | The actions recommended by the physician or those initiated by the patient and are associated with words that express symptoms. | Day 1 | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
| Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
| Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
| Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
| Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
| Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
| Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
| Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
| Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
| Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
| Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
| Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
| Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
| Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
| Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
| Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
| Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
| Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|